Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Alta Partners"


2 mentions found


Read previewLivongo veteran Glen Tullman's latest venture, healthcare startup Trascarent, is raising a Series D round, Business Insider has learned. The sources said the round values Transcarent at about $2.1 billion. Related storiesIt's been a difficult fundraising environment for growth-stage healthcare startups — and that's reflected in Transcarent's latest fundraising push. Transcarent has raised $298 million to date, last grabbing $200 million in a January 2022 Series C round that boosted its valuation to $1.6 billion. Transcarent also acquired 98point6's virtual care platform in March 2023 to offer on-demand telehealth care.
Persons: , Glen Tullman's, General Catalyst, Leslie Krigstein, Transcarent, Tullman, Teladoc, 98point6 Organizations: Service, General, Business, Catalyst, Human, Ally, Group, Alta Partners, Merck Global Health Innovation Fund, Jove Equity, Ventures, GreatPoint Ventures, Intermountain Healthcare, Rush University Medical, Soda Health Locations: Transcarent
Oak HC/FT, NEA, and other investors backed Everside Health in its $164 million July funding round. Everside Health is one of the few startups that these trends don't apply to. Chris Miller, the CEO of Everside, and Dr. Stephen Wills at an Everside Health center in Denver, Colorado. Everside Health shared the presentation it used to bank $164 million in July with Insider. Here's the 13-slide presentation Everside Health used to raise a $164 million funding round led by NEA.
Total: 2